(2HRA) H&R GmbH . KGaA - Ratings and Ratios

H&R GmbH & Co. KGaA specializes in the production and distribution of chemical-pharmaceutical raw materials and precision plastic components. Established in 1919 and headquartered in Salzbergen, Germany, the company operates through three key segments: ChemPharm Refining, ChemPharm Sales, and Plastics. It serves diverse industries, including medical technology, automotive, and traditional manufacturing, emphasizing innovation and sustainability in its operations. The companys product portfolio includes paraffins, white oils, plasticizers, and medical consumables, catering to both industrial and healthcare sectors. H&R GmbH & Co. KGaA is committed to quality and precision, ensuring its products meet stringent industry standards. The companys strategic focus includes expanding its market presence and developing eco-friendly solutions to align with global sustainability trends.

The ChemPharm Refining segment manufactures and distributes specialty products such as paraffins, white oils, and lubricants, alongside feedstocks and bunker fuels. This segment is crucial for providing essential raw materials to various industries. The ChemPharm Sales segment focuses on processing and distributing plasticizers, wax emulsions, and other specialty products, ensuring a steady supply chain for its clients. The Plastics segment is dedicated to developing precision plastic parts and medical consumables, leveraging advanced technologies to meet the exacting demands of medical technology and automotive industries. This diversification allows H&R to maintain a robust market position across multiple sectors.

As of the latest data, H&R GmbH & Co. KGaA is listed on the XETRA exchange under the ticker symbol 2HRA. The companys market capitalization stands at 126.18M EUR, with a price-to-earnings ratio of 13.56, indicating moderate valuation. The price-to-book ratio of 0.31 suggests potential undervaluation relative to its assets. With a price-to-sales ratio of 0.10, the stock is attractively priced for investors focused on sales growth. The return on equity is 1.31, reflecting modest profitability. These fundamental factors, combined with technical indicators, provide a comprehensive view for investors assessing the companys potential.

3-Month Forecast: - Price Range: The stock is anticipated to trade between 3.50 and 3.90 EUR, influenced by its proximity to the 20 and 50-day SMAs and low volatility indicated by an ATR of 0.09. - Support and Resistance: Support is expected at 3.59 (SMA20) and resistance at 3.93 (SMA200). Breaking above resistance could signal an uptrend, while failure to hold support may lead to a downtrend. - Volatility: The low ATR suggests minimal price fluctuations, indicating a stable trading environment. - Fundamental Impact: The companys moderate P/E and low P/B may attract value investors, potentially influencing positive price movement. - Market Sentiment: Investors may view the stock favorably due to its low valuation metrics, which could drive demand and support price stability or gradual increase. This forecast is based on technical trends and fundamental analysis, providing a data-driven outlook for the next quarter.